Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Antidiabetogenic Effect of Glucagon-like Peptide-1 (736)amide in normal subjects and patients with diabetes mellitus
Horwich, T
Third-party testing by MZ Biolabs using mass spectrometry, COA access per batch, refund and shipping policy details
In a clinical study of 10 subjects, up to 20% to 25% fat layer reduction was seen at 2 and 6 months
Regulatory watch Last reviewed Jul 1, 2026 Next review Jul 29, 2026 Evidence snapshot AOD-9604 was developed by Metabolic Pharmaceuticals (Australia) as a modified C-terminal fragment (residues 177-191) of human growth hormone, designed to retain lipolytic activity without growth-promoting effects
US$ 20.42
US$ 28.46
US$ 28.13
US$ 23.28
US$ 29.79
US$ 27.39
US$ 22.66
